Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caffeine disposition in obesity.

D R Abernethy, E L Todd, J B Schwartz

    British Journal of Clinical Pharmacology
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Obese individuals exhibit increased caffeine distribution, impacting loading doses but not chronic dosing. Caffeine clearance, a measure of liver enzyme activity, remains unchanged in obesity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tyrosine kinase-targeting drugs-associated heart failure.

    British journal of cancer·2017
    Same author

    GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near-Term Efforts in the Field.

    CPT: pharmacometrics & systems pharmacology·2016
    Same author

    Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5.

    Clinical pharmacology and therapeutics·2016
    Same author

    Application of systems pharmacology to explore mechanisms of hepatotoxicity.

    Clinical pharmacology and therapeutics·2014
    Same author

    Use of internet search logs to evaluate potential drug adverse events.

    Clinical pharmacology and therapeutics·2014
    Same author

    Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan.

    The journal of nutrition, health & aging·2014
    Same journal

    Anticholinergic and central nervous system-active drug burdens and their associations with adverse in-hospital outcomes among older inpatients.

    British journal of clinical pharmacology·2026
    Same journal

    N-acetylcysteine for non-paracetamol-induced acute liver failure in children: A systematic review and meta-analysis.

    British journal of clinical pharmacology·2026
    Same journal

    Anti-seizure medications and DRESS in paediatric patients: A FAERS disproportionality and time-to-onset analysis.

    British journal of clinical pharmacology·2026
    Same journal

    Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment.

    British journal of clinical pharmacology·2026
    Same journal

    The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

    British journal of clinical pharmacology·2026
    Same journal

    Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

    British journal of clinical pharmacology·2026
    See all related articles

    Area of Science:

    • Pharmacokinetics
    • Obesity Research
    • Drug Metabolism

    Background:

    • Caffeine pharmacokinetics can be altered by body weight.
    • Understanding drug distribution in obese populations is crucial for accurate dosing.

    Purpose of the Study:

    • To investigate caffeine pharmacokinetics in obese versus normal-weight individuals.
    • To determine the impact of obesity on caffeine distribution and clearance.

    Main Methods:

    • 16 obese and 23 normal-weight subjects ingested 162 mg of caffeine.
    • Plasma caffeine concentrations were measured over 24 hours.
    • Pharmacokinetic variables, including volume of distribution and oral clearance, were calculated.

    Main Results:

    Related Experiment Videos

  • Obese subjects showed a significantly increased apparent volume of distribution for caffeine.
  • Oral clearance of caffeine was not significantly different between obese and normal-weight subjects.
  • Caffeine clearance did not correlate with body weight, suggesting stable cytochrome P450 activity.

    • Conclusions:

    • Caffeine's distribution is significantly influenced by total body weight in obesity.
    • Therapeutic loading doses of caffeine should be adjusted based on total body weight.
    • Chronic caffeine dosing regimens do not require alteration due to obesity as clearance remains constant.